Infinium Pharmachem Ltd Reports Net Profit of Rs 6.13 crore in H1FY23, growth of 22.7 per cent Y-o-Y
Oct 30, 2023
Gujarat [India], October 30: Infinium Pharmachem Ltd, engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported a standalone net profit of Rs 6.13 crore for H1FY24 ended September 2023 with Y-o-Y growth of 22.7 per cent as compared to the net profit of Rs 4.99 crore in H1FY23. The reduction in the raw material costs and operational efficiency have contributed to the profit growth. Revenue from Operations in H1FY24 was reported at Rs 50.85 crore. Profit Before Tax during H1FY24 grew 22.3 per cent to Rs 8.17 crore as against Profit before Tax of Rs 6.68 crore in H1FY23. EPS for H1FY24 was reported at Rs 4.41 per share.